Effects of 4-aminopyridine on neuromuscular transmission
- PMID: 210882
- DOI: 10.1016/0006-8993(78)90409-2
Effects of 4-aminopyridine on neuromuscular transmission
Abstract
4-Aminopyridine (4-AP) powerfully increases transmitter release from motor nerve terminals of rat and frog skeletal muscle in response to single nerve impulses. The drug also enhances transmitter release during repetitive nerve activity but, at D-tubocurarine-blocked endplates, only the first impulses cause increased transmitter release at stimulation frequencies at or above 50 Hz. At magnesium- and botulinum-poisoned endplates, 4-AP potentiates transmitter release at every stimulus during tetanic nerve stimulation and restores neuromuscular transmission. Spontaneous transmitter release in the rat is not affected by the drug, but at some frog endplates miniature endplate potential (mepp) frequency increases. The drug has no post-synaptic action, as evidenced by its lack of effect on amplitude or time course of mepps. Decreasing the temperature from 37 to 15 degrees C does not abolish the effect of 4-AP on neuromuscular transmission. In the presence of 4-AP, single nerve impulses produce repetitive spontaneous activity in the nerve terminal of the frog nerve-muscle preparation. Experiments on the mode of action of 4-AP suggest that the drug increases transmitter release by enhancing the influx of calcium ions during depolarization of the nerve terminal.
Similar articles
-
Facilitatory effects of 4-aminopyridine on normal neuromuscular transmission.Muscle Nerve. 1980 Mar-Apr;3(2):105-11. doi: 10.1002/mus.880030202. Muscle Nerve. 1980. PMID: 6245354
-
4-Aminopyridine and evoked transmitter release from motor nerve endings.Br J Pharmacol. 1978 Dec;64(4):623-9. doi: 10.1111/j.1476-5381.1978.tb17325.x. Br J Pharmacol. 1978. PMID: 31961 Free PMC article.
-
Increase in transmitter release from motor nerve terminals induced by some pyridine derivatives.Acta Physiol Pharmacol Latinoam. 1984;34(4):409-18. Acta Physiol Pharmacol Latinoam. 1984. PMID: 6242265
-
[Presynaptic effects of aminopyridines on the neuromuscular junction of vertebrates].J Pharmacol. 1985;16 Suppl 2:109-44. J Pharmacol. 1985. PMID: 2417060 Review. French.
-
Spontaneous transmitter release at the neuromuscular junction.Fundam Clin Pharmacol. 1988;2(2):89-101. doi: 10.1111/j.1472-8206.1988.tb00625.x. Fundam Clin Pharmacol. 1988. PMID: 2899044 Review.
Cited by
-
Effect of 4-Aminopyridine on Action Potential Parameters in Isolated Dog Purkinje Fibers.Arch Drug Inf. 2010 Mar;3(1):19-25. doi: 10.1111/j.1753-5174.2009.00027.x. Arch Drug Inf. 2010. PMID: 20428229 Free PMC article.
-
Effect of the putative cognitive enhancer, linopirdine (DuP 996), on quantal parameters of acetylcholine release at the frog neuromuscular junction.Br J Pharmacol. 1994 Apr;111(4):1103-10. doi: 10.1111/j.1476-5381.1994.tb14858.x. Br J Pharmacol. 1994. PMID: 8032596 Free PMC article.
-
Treatment for Lambert-Eaton myasthenic syndrome.Cochrane Database Syst Rev. 2011 Feb 16;2011(2):CD003279. doi: 10.1002/14651858.CD003279.pub3. Cochrane Database Syst Rev. 2011. PMID: 21328260 Free PMC article.
-
Stimulation of phrenic nerve activity by an acetylcholine releasing drug: 4-aminopyridine.Pflugers Arch. 1979 Mar 16;379(2):181-5. doi: 10.1007/BF00586945. Pflugers Arch. 1979. PMID: 571113
-
Seizures are a druggable mechanistic link between TBI and subsequent tauopathy.Elife. 2021 Feb 2;10:e58744. doi: 10.7554/eLife.58744. Elife. 2021. PMID: 33527898 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources